Digestive Diseases and Sciences

, Volume 38, Issue 3, pp 449–456 | Cite as

Types, causes, and therapies of hepatitis occurring in liver transplant recipients

  • S. Fagiuoli
  • G. Shah
  • H. I. Wright
  • D. H. Van Thiel
Review Article
Received:
Revised:
Accepted:

Abstract

Liver transplantation (OLTx) has become a common life-saving procedure for individuals with chronic advanced liver disease. It is also used in the clinical treatment of patients with fulminant hepatic failure and those with primary neoplastic disease of the liver. Despite its overall success in restoring meaningful life to those who undergo the procedure, the posttransplant life of a liver allograft recipient is not without hazard. A common problem following liver transplantation is the finding of abnormal liver injury tests reflecting a “hepatitis” that can not be ascribed to allograft rejection. The majority of such cases are a consequence of either a technically flawed operation, drug-induced liver injury, or one or another form of viral hepatitis. Each of these problems is discussed in the following clinical review.

Key Words

liver transplant liver injury tests hepatitis 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wright HI, Bou-Abboud CF, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH: Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 53:136–139, 1992Google Scholar
  2. 2.
    Portman B, O'Grady J, Williams R: Disease recurrence following orthotopic liver transplantation. Transplant Proc 18(suppl 4):136–143, 1986Google Scholar
  3. 3.
    Neuhaus P, Broelsch CH, Ringe B, et al: Results of biliary reconstruction after liver transplantation. Transplant Proc 16:1225–1227, 1984Google Scholar
  4. 4.
    Iwatsuki S, Shaw BW Jr, Starzl TE: Biliary tract complications in liver transplantation under cyclosporin-steroid therapy. Transplant Proc 15:1288–1291, 1983Google Scholar
  5. 5.
    Lerut J, Gordon RD, Iwatsuki S, et al: Biliary tract complications in human orthotopic liver transplantation. Transplantation 43:47–50, 1987Google Scholar
  6. 6.
    Ringe B, Olkhafer K, Bunzendahl H, et al: Analysis of biliary complications following orthotopic liver transplantation. Transplant Proc 21:2472–2476, 1989Google Scholar
  7. 7.
    Wall WJ, Grant DR, Mimeault RE, et al: Biliary reconstruction in liver transplantation. Can J Surg 32:97–100, 1989Google Scholar
  8. 8.
    Koneru B, Zajko AB, Sher L, et al: Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet 168:394–396, 1989Google Scholar
  9. 9.
    Halff G, Todo S, Hall R, et al: Late complications with the gallbladder conduit biliary reconstruction after transplantation. Transplantation 48:537–539, 1989Google Scholar
  10. 10.
    Mika SK: The terminal distribution of the hepatic artery with special reference to arterio-portal anastomosis. J Anat 100:651–663, 1966Google Scholar
  11. 11.
    Shaw BW Jr, Gordon RD, Iwatsuki S, et al: Hepatic retransplantation. Transplant Proc 17:264–271, 1985Google Scholar
  12. 12.
    Paulsen AW, Brajtbord D, Klintmalm GB, et al: Intraoperative measurements related to subsequent hepatic graft failure. Transplant Proc 21:2337–2338, 1989Google Scholar
  13. 13.
    Quiroga J, Colina I, Demetris J, Starzl TE, Van Thiel DH: Causes and timing of first allograft failure in orthotopic liver transplantation: A study in 177 consecutive patients undergoing liver retransplantation. Hepatology 14:1054–1062, 1991Google Scholar
  14. 14.
    Tzakis AG, Gordon RD, Shaw BW Jr, et al: Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 40:667–671, 1985Google Scholar
  15. 15.
    Klintmalm BG, Olson LM, Nery JR, et al: Treatment of hepatic artery thrombosis after liver transplantation with immediate vascular reconstruction: A report of three cases. Transplant Proc 20(suppl 1):610–612, 1988Google Scholar
  16. 16.
    Mazzaferro V, Esquivel CO, Makowka L, et al: Hepatic artery thrombosis after pediatric liver transplantation: Medical or surgical event? Transplantation 47:971–977, 1989Google Scholar
  17. 17.
    Lerut J, Tzakis AG, Bron K, et al: Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 205:404–414, 1987Google Scholar
  18. 18.
    Wozney P, Zajko AB, Bron KM, et al: Vascular complications after liver transplantation: A 5-year experience. AJR 147:657–663, 1986Google Scholar
  19. 19.
    Zajko AB, Campbell WL, Logsdon GA, et al: Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR 149:485–489, 1987Google Scholar
  20. 20.
    Demetris AJ, Jaffe R, Starzl TE: A review of adults and pediatric post-transplant liver pathology. Pathol Annu 22:347–386, 1987Google Scholar
  21. 21.
    Burke GW, Ascher NL, Hunter D, et al: Orthotopic liver transplantation: nonoperative management of early, acute portal vein thrombosis Surgery 104:924–928, 1988Google Scholar
  22. 22.
    Scantlebury V, Zajko A, Esquivel C, et al: Successful reconstruction of late portal vein stenosis after hepatic transplantation. Arch Surg 124:503–505, 1989Google Scholar
  23. 23.
    Rouch DA, Emond JC, Ferrari M, et al: The successful management of portal vein thrombosis after hepatic transplantation with the splenorenal shunt. Surg Gynecol Obstet 166:311–316, 1988Google Scholar
  24. 24.
    Van Thiel DH, Fagiuoli S, Wright HI, Rodriguez-Rilo H, Silverman W: Biliary Complications of liver transplantation: A review for gastroenterologists and surgeons not at a transplant center. Gastrointes Endosc (in press)Google Scholar
  25. 25.
    Iwatsuki S, Shaw BW, Starzl TE: Biliary tract complications in liver transplantation under cyclosporine-steroid therapy. Transplant Proc 15:1288–1291, 1983Google Scholar
  26. 26.
    Vicente E, Perkins JD, Sterioff S, et al: Biliary tract complications following orthotopic liver transplantation. Clin Transplant 1:138–142, 1987Google Scholar
  27. 27.
    Lerut J, Gordon RD, Iwatsuki, S, et al: Biliary tract complications in human orthotopic liver transplantation. Transplantation 43:47–51, 1987Google Scholar
  28. 28.
    Schade RR, Guglielmi A, Van Thiel DH, et al: Cholestasis in heart transplant recipients treated with cyclosporine. Transplant Proc 15:2757–2760, 1983Google Scholar
  29. 29.
    Klintmalm GBG, Iwatsuki S, Starzl TE: Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 32:488–489, 1981Google Scholar
  30. 30.
    Todo S, Podesta L, ChapChap P, et al: Orthotopic liver transplantation in dogs receiving FK 506. Transplant Proc 19(suppl 6):64–67, 1987Google Scholar
  31. 31.
    Todo S, Ueda Y, Demetris AJ et al: Immunosuppression of canine, monkey, and baboon allografts by FK 506 with special reference to synergism with other drugs, and to tolerance induction. Surgery 104:239–249, 1988Google Scholar
  32. 32.
    McDonald GB, Triumali N: Intestinal and liver toxicity of neoplastic drugs. West J Med 140:250–295, 1984Google Scholar
  33. 33.
    Weitz H, Gakel JM, Possinger K, et al: Venoocclusive disease of the liver in patients receiving immunosuppressive therapy. Virchow's Arch (Pathol Anat) 395:245–253, 1982Google Scholar
  34. 34.
    Marubbio AT, Danielson B: Hepatic venoocclusive disease in a renal transplant patient receiving azathioprine. Gastroenterology 69:739–743, 1975Google Scholar
  35. 35.
    De Pinho RA, Goldberg CS, Lefkowitch JH: Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. Gastroenterology 86:162–165, 1984Google Scholar
  36. 36.
    Sterneck M, Wiesner R, Asher N, Roberts J, Ferrel L, Ludwig J, Lake J: Azathioprine hepatotoxicity after liver transplantation. Hepatology 14:806–810, 1991Google Scholar
  37. 37.
    Lewis JH, Zimmerman HJ, Benson GD, Ishak KG: Hepatic injury associated with ketoconazole therapy. Gastroenterology 86:503–513, 1984Google Scholar
  38. 38.
    Stricker BHCh, Blok APR, Bronkhorst FB, Van Parys GE, Desmet VJ: Ketoconazole-associated hepatic injury; A clinicopathological study of 55 cases. J Hepatol 3:399–406, 1986Google Scholar
  39. 39.
    Lake-Bakaar G, Scheuer PJ, Sherlock S: Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J 294:419–422, 1987Google Scholar
  40. 40.
    Knight TE, Shikuma CY, Knight J: Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol 25:398–400, 1991Google Scholar
  41. 41.
    Gasbarrini A, Borle AB, Van Thiel DH: Ca2+ channel blockers do not protect isolated perfused rat hepatocytes from anoxic injury. Biochim Biophys Acta (in press)Google Scholar
  42. 42.
    Brodsky SJ, Cutler SS, Weiner DA, Klein MD: Hepatotoxicity due to treatment with verapamil. Ann Intern Med 94:490–491, 1981Google Scholar
  43. 43.
    Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, Van Thiel DH: Incidence, prevalence and clinical course of hepatitis C in liver transplantation: Experience in 317 donor and recipient pairs. Gastroenterology 103:323–329, 1992Google Scholar
  44. 44.
    Lake JR, Wright TL: Liver transplantation for patients with hepatitis B: What have we learned from our results? Hepatology 13:796–799, 1991Google Scholar
  45. 45.
    Wright TL, Donegan E, Hsu HH, Ferrel L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Asher NL, Greenberg HB: Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103:317–322, 1992Google Scholar
  46. 46.
    Colledan M, Gislon M, Doglia M, et al: Liver transplantation in patients with B viral hepatitis and delta infection. Transplant Proc 19:4073–4076, 1987Google Scholar
  47. 47.
    Rizzetto M, Macagno S, Chiaberge E, et al: Liver transplantation in hepatitis delta virus disease. Lancet 2:469–471 1987Google Scholar
  48. 48.
    Todo S, Demetris AJ, Van Thiel DH, Fung JJ, Starzl TE: Orthotopic liver transplantation for patients with hepatitis B virus (HBV) related liver disease. Hepatology 13:619–626, 1991Google Scholar
  49. 49.
    Rakela J: Recurrent hepatitis B infection in hepatic allografts. Mayo Clin Proc 64:597–599, 1989Google Scholar
  50. 50.
    Yoffe B, Müller R: Liver transplantation in patients with HBV infection: Implications of extrahepatic HBV infection.In Viral Hepatitis and Liver Disease. FB Hollinger SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1991, pp 813–819Google Scholar
  51. 51.
    Omata M: Significance of extrahepatic replication of hepatitis B virus. Hepatology 12:364–366, 1990Google Scholar
  52. 52.
    Lednar WM, Lemon SM, Kirkpatrick JW, et al: Frequency of illness associated with hepatitis A virus infection in adults. Am J Epidemiol 122:226–233, 1985Google Scholar
  53. 53.
    Yao G: Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1991, pp 76–78.Google Scholar
  54. 54.
    Balayan MS: HEV infection: Historical perspectives, global epidemiology and clinical features.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1991, pp 498–507Google Scholar
  55. 55.
    Wertheim RA, Brooks BJ Jr, Rodriguez FH Jr, Lesesne HR, Jennette JC: Fatal herpetic hepatitis in pregnancy. Obstet Gynecol 62(suppl):38S-42S, 1983Google Scholar
  56. 56.
    Van Thiel DH, Dindzans VJ, Gavaler JS, Tarter RE: The postoperative problems and management of the liver transplant recipient. Prog Liver Dis 9:657–685, 1990Google Scholar
  57. 57.
    Alexander JA, Demetris AJ, Gavaler JS, Makowka L, Starzl TE, Van Thiel DH: Pancreatitis following liver transplantation. Transplantation 45:1062–1065, 1988Google Scholar
  58. 58.
    Demetris AJ, Jaffe R, Sheahan DG, et al: Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 125:161–172, 1986Google Scholar
  59. 59.
    Davies SE, Portmann B, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R: Hepatic histology following transplantation for chronic hepatitis B virus infection including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13:150–157, 1991Google Scholar
  60. 60.
    Corman JL, Putnam CW, Iwatsuki S, et al: Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg 114:75–78, 1979Google Scholar
  61. 61.
    Block GD, Van Thiel DH, Todo S, Starzl TE: Interferonalfa-2b improves survival in patients transplanted for chronic liver failure due to hepatitis B. J Hepatol (in press)Google Scholar
  62. 62.
    Van Thiel DH, Wright HI, Gavaler JS, Fung J, Starzl TE: Interferon therapy of hepatitis following transplantation under FK 506 or cyclosporine A. Transplant Proc 23:3052–3053, 1991Google Scholar
  63. 63.
    Wright HI, Gavaler JS, Van Thiel DH: Preliminary experience with α 2b interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 53:121–124, 1992Google Scholar
  64. 64.
    Smedile A, Marzano A, Farci P, Chiaberge E, Abate A, Ottobrelli A, Brunetto MR, Rosina F, Durazzo M, Verme G, Bonino F, Rizzetto M: Liver transplant for viral hepatitis. Recurrence of reinfection. J Hepatol 13:S134-S137, 1991Google Scholar
  65. 65.
    Van Thiel DH, Fung JJ, Todo S, Demetris AJ, Starzl TE: Liver transplantation for viral liver disease.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore. Williams & Wilkins, 1991, pp 629–631Google Scholar
  66. 66.
    Fung J, Ostberg L, Shapiro R, Todo S, Demetris A, Starzl TE: Human monoclonal antibody against hepatitis B surface antigen in preventing recurrent hepatitis B following liver transplantation.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1991, pp 651–654Google Scholar
  67. 67.
    Ming W, Todo S, Fung JJ, Van Thiel DH, Starzl TE, Demetris AJ: Analysis of hepatitis B viral antigen expression in liver allografts: Correlation with HBV serology and histopathology. Hepatology (in press)Google Scholar
  68. 68.
    Samuel D, Bismuth H, Methieu D, et al: Passive immunoprophylaxis after liver transplantation in HBsAg positive patients. Lancet 337:813–815, 1991Google Scholar
  69. 69.
    Hsu HM, Chen DS, Chuang CH, Lu JCF, Two DM, Lee CC, Lu HC, Cheng SH, Wang Chen C, Lo KJ, Shih CJ, Sung JL, The Hepatitis Control Committee, The Hepatitis Steering Committee: Efficacy of a mass hepatitis B vaccination program in Taiwan. JAMA 260:2231–2235, 1988Google Scholar
  70. 70.
    Pereira BJG, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 321:454–460, 1991Google Scholar
  71. 71.
    Diethelm AG, Roth D, Gerguson RM, Schiff ER, Hardy MA, Starzl TE, Miller J, Van Thiel DH, Najarian JS: Transmission of HCV by organ transplantation. N Engl J Med 326:410–411, 1992 (letter)Google Scholar
  72. 72.
    Davis CL: The prevention of cytomegalovirus disease in renal transplantation. Am J. Kidney Dis 16:175, 1990Google Scholar
  73. 73.
    Paya CV, Hermans PE, Smith TF, et al: Efficacy of gancyclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 46:229–234, 1988Google Scholar
  74. 74.
    Hanto DW, Frizzera G, Peczalska G, et al: Epstein-Barr virus induced B cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B cell proliferation. N Engl J Med 306:913–918, 1982Google Scholar
  75. 75.
    Awad J, Peters MG, Brunt E, Hanto DW: Herpes viral hepatitis in liver transplant recipients. Clin Transplant 6:16–20, 1992Google Scholar
  76. 76.
    Demetris AJ, Jaffe R, Starzl TE: A review of adults and pediatric post-transplant liver pathology. Pathol Annu 22:347–386, 1987Google Scholar
  77. 77.
    Demetris AJ, Kakizoe S, Oguma S: Pathology of liver transplantation.In Hepatic Transplantation. JW William (ed). Philadelphia, WB Saunders, 1990, pp 60–113Google Scholar
  78. 78.
    O'Brien J, Campoli-Richards DM: Acyclovir—an updated review of its antiviral activity, pharmacokinetic properties, and therapeutic efficacy. Drugs 37:233, 1989Google Scholar
  79. 79.
    Breinig MK, Zitelli B, Starzl TE, Ho M: Epstein-Barr virus, cytomegalovirus and other viral infections in children after liver transplantation. J Infect Dis 157:273–279, 1987Google Scholar
  80. 80.
    Ho M, Miller G, Atchison RW, et al: Epstein-Barr virus infections and DNA hybridization studies post-transplantation lymphoma and lymphoproliferative lesions. J Infect Dis 152:876–886, 1985Google Scholar
  81. 81.
    Nalesnik MA, Makowka L, Starzl TE: The diagnosis and treatment of post-transplant lymphoproliferative disease. Curr Prob Surg 25:37–47, 1988Google Scholar
  82. 82.
    Psacharopoulos HT, Morat AP, Davies M, Portmann B, Silk DBA, Williams R: Fulminant hepatic failure in childhood. An analysis of 31 cases. Arch Dis Childhood 52:252–258, 1980Google Scholar
  83. 83.
    Singh N, Dummer JS, Kusne S, et al: Infections with cytomegalovirus and other herpes viruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 158:124–131, 1988Google Scholar
  84. 84.
    Paya CV, Hermans PE, Wiesner RH, et al: Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 160:752, 1989Google Scholar
  85. 85.
    Koneru B, Atchison R, Jaffe R, Van Thiel DH, Starzl TE: Serological Studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 22:1547–1548, 1990Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • S. Fagiuoli
    • 1
  • G. Shah
    • 1
  • H. I. Wright
    • 1
  • D. H. Van Thiel
    • 1
  1. 1.Department of SurgeryUniversity of Pittsburgh School of MedicinePittsburgh

Personalised recommendations